False Negativity of Targeted Axillary Dissection in Breast Cancer

Introduction: Targeted axillary dissection (TAD) has been proposed as an alternative method for the staging of patients with node-positive breast cancer who undergo neoadjuvant chemotherapy. However, not much is known yet about the false-negative rate (FNR) of the method and the subsequent risk of u...

Full description

Saved in:
Bibliographic Details
Published in:Breast care (Basel, Switzerland) Switzerland), 2021-10, Vol.16 (5), p.532-538
Main Authors: Kirkilesis, George, Constantinidou, Anastasia, Kontos, Michalis
Format: Article
Language:English
Subjects:
Systematic Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction: Targeted axillary dissection (TAD) has been proposed as an alternative method for the staging of patients with node-positive breast cancer who undergo neoadjuvant chemotherapy. However, not much is known yet about the false-negative rate (FNR) of the method and the subsequent risk of underestimation of residual axillary disease. Methods: This study reviews published articles with calculations of false negativity of TAD and potential factors that may influence it. Results: The FNR of TAD is usually reported as being
ISSN:1661-3791
1661-3805
DOI:10.1159/000513037